Trials / Unknown
UnknownNCT05010044
MBCT for Psoriasis Patients With Anxiety and Depression
Mindfulness-based Cognitive Therapy for Psoriasis Patients With Anxiety and Depression
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- First Affiliated Hospital Xi'an Jiaotong University · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
This study investigates the effectiveness of a 24-week mindfulness intervention in reducing symptoms in psoriasis patients with anxiety and depression.
Detailed description
An adapted MBCT intervention will be offered to people with psoriasis with depression and/or anxiety. 8-week long MBCT therapy will be held between August 2021 and Jan 2022, based on the adapted protocol. The MBCT intervention will consist of 30-minute weekly groups focused on teaching mindfulness techniques and ways to recognize cognitive patterns that can increase anxiety and/or depression. Participants will be recruited from the community, according to the eligibility criteria detailed below. For all participants, anxiety and/or depressive symptom severity(SAS/SDS), PASI,DLQI,(as measured with standardized, validated scales) will be compared baseline and weeks 2;4;8;12;16;20;24. Itch intensity ,itch perception ,quality of sleep, hours missing at work ,helpfulness of common itch therapies serve as the secondary outcome, using a paired t-test.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | mindfulness-based cognitive therapy (MBCT) | Mindfulness- Based Cognitive Therapy (MBCT) It involves practicing to be present 'in the moment' and an attitude of non- judgmental acceptance with the aim to maintain awareness, disengaging oneself from strong attachment and thereby developing a greater sense of emotional balance and well-being. |
| OTHER | Antipsoriatic treatment | The routine drug therapy for psoriasis. |
Timeline
- Start date
- 2021-08-01
- Primary completion
- 2022-01-01
- Completion
- 2022-01-01
- First posted
- 2021-08-18
- Last updated
- 2021-08-18
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05010044. Inclusion in this directory is not an endorsement.